SynthesisAdvances in therapy2018

Non-medical Switching from Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies.

Syed Numan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.